Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ -1.03EBITDA per Share
VS
Market
Sector
Industry
History
$ 6.09Close
$ 4.52 - $ 10.98 52-Week Range
Ticker Information
Ticker
NVCTCompany Name
NUVECTIS PHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQNUVECTIS PHARMA INC - EBITDA per Share Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
NVCT - EBITDAPS Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA per Share | Share Factor | Weighted Average Shares |
|---|---|---|---|---|
| 6/30/2025 | $ -22.07M | $ -1.03 | 1 | 21.37M |
| 3/31/2025 | $ -20.16M | $ -1.01 | 1 | 19.94M |
| 12/31/2024 | $ -19M | $ -1.11 | 1 | 17.11M |
| 9/30/2024 | $ -19.37M | $ -1.12 | 1 | 17.23M |
| 6/30/2024 | $ -21.1M | $ -1.25 | 1 | 16.9M |
| 3/31/2024 | $ -22.38M | $ -1.35 | 1 | 16.56M |
| 12/31/2023 | $ -22.26M | $ -1.43 | 1 | 15.56M |
| 9/30/2023 | $ -22.33M | $ -1.39 | 1 | 16.1M |
| 6/30/2023 | $ -22.33M | $ -1.47 | 1 | 15.18M |
| 3/31/2023 | $ -20.19M | $ -1.37 | 1 | 14.72M |
Key Performance Insights, Last 5 Years
- NUVECTIS PHARMA INC's latest trailing twelve months (TTM) EBITDAPS stands at $ -0.1.
- Over the past 5 years, NUVECTIS PHARMA INC's average EBITDAPS has been $ -1.28.
- The median EBITDAPS for NUVECTIS PHARMA INC during this period was $ -1.25
- NUVECTIS PHARMA INC reached its highest EBITDAPS over the past 5 years at $ -0.1.
- The lowest EBITDAPS recorded by NUVECTIS PHARMA INC in the same timeframe $ -3.02
Similar metrics to Shares WA:
- EBIT per Share - [Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Book Value per Share - [Calculation] The amount of equity attributed to each share, calculated as [Equity] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Sales per Share - [Calculation] The amount of revenue attributed to each share, calculated as [Revenue] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Free Cash Flow per Share - [Calculation] The amount of Free Cash Flow attributed to each share, calculated as [FCF] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of EBITDA per Share
[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS EBITDAPS for NUVECTIS PHARMA INC is calculated as follows: EBITDA [ $ -10K ] / (Shares WA [ 100K ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -0.1 ] NVCT - EBITDA per Share, Last 5 years
$ -3.02
Minimum
Dec 31, 2021
$ -0.1
Maximum
Dec 31, 2020
$ -1.28
Average
$ -1.25
Median
EBITDAPS Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.01 with a standard deviation of $ 4.26.
The following table provides additional summary stats:
EBITDAPS in the Market:
| filtered constituents | 3.78K |
|---|---|
| min | $ -10.86 |
| max | $ 13.95 |
| average | $ 2.01 |
| median | $ 0.99 |
| std | $ 4.26 |